Medical Group Management Association
Join Now

Government Advocacy

The voice of medical practices in Washington

Engage with a team that advocates on your behalf and translates complex regulations into focused updates on the latest health issues from Washington.

Advocacy Letter

October 3, 2022: MGMA submits comments on proposed rule amending regulations under Section 1557 of the Affordable Care Act

Advocacy Letter

September 30, 2022: MGMA and leading health organizations express support for legislation to mitigate Medicare reimbursement cuts

Advocacy Letter

September 28, 2022: MGMA and over 800 other organizations ask Congress to extend the Medicare APM incentive payments

Advocacy Letter

September 27, 2022: MGMA and partner organizations urge CMS to create appropriate policies for future requirements under the No Surprises Act

Advocacy Letter

September 26, 2022: MGMA and and other health IT stakeholders urge HHS to postpone upcoming information blocking compliance deadlines

Press Statement

September 21, 2022: MGMA statement on Medicare payment reduction findings

Press Statement

September 14, 2022: MGMA statement on House passage of the Improving Seniors' Timely Access to Care Act

Advocacy Letter

September 13, 2022: MGMA and partner organizations urge Senate leadership to extend telehealth flexibilities

Advocacy Letter

September 13, 2022: MGMA and coalition partners provide comment to CMS on the 2023 OPPS proposed rule

Press Statement

September 13, 2022: MGMA statement on the Supporting Medicare Providers Act of 2022

Advocacy Letter

September 12, 2022: MGMA legislative recommendations to support group practices in 2023

Advocacy Letter

September 8, 2022: MGMA and other leading healthcare organizations urge Congress to protect patient access to clinical laboratory services

Advocacy Letter

September 6, 2022: MGMA provides comprehensive comments on 2023 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 1, 2022: MGMA and partner organizations submit comments supporting value-based care in the 2023 proposed Physician Fee Schedule

Advocacy Letter

August 31, 2022: MGMA and partner organizations request information from CMS regarding Medicare Advantage

Advocacy Letter

August 31, 2022: MGMA provides recommendations to improve Medicare Advantage

Advocacy Letter

August 18, 2022: MGMA and partner organizations request additional clarity and guidance surrounding information blocking regulations

Advocacy Letter

August 11, 2022: MGMA urges HHS to provide 90-day notice prior to end of COVID-19 PHE

Advocacy Letter

August 2, 2022: MGMA urges appropriate implementation timeline for No Surprises Act enforcement

Advocacy Letter

July 27, 2022: MGMA and partner organizations urge Congress to take action to mitigate pending Medicare cuts

Press Statement

July 27, 2022: MGMA statement on the Improving Seniors' Timely Access to Care Act

Advocacy Letter

July 20, 2022: MGMA urges swift passage of the GOLD CARD Act of 2022

Advocacy Letter

July 18, 2022: MGMA and partner organizations urge Congress for increased Medicare support for GME

Press Statement

July 7, 2022: MGMA statement on CMS' proposed 2023 Medicare Physician Fee Schedule

Advocacy Letter

June 13, 2022: MGMA and partner organizations urge HHS for additional education opportunities on information blocking laws and request warning communications prior to disincentives

Advocacy Letter

June 6, 2022: MGMA provides recommendations to HHS on certain provisions from the HITECH Act

Advocacy Letter

June 1, 2022: MGMA and partner organizations urge CMS to reinstate step therapy prohibition in Medicare Advantage for Part B drugs

Advocacy Letter

May 27, 2022: MGMA and partner organizations urge Congress to pass legislation to advance equity and address the social determinants of health

Advocacy Letter

May 22, 2022: MGMA and leading health organizations urge Congress to further refine VALID Act

Advocacy Letter

May 18, 2022: MGMA and other leading healthcare organizations write to CMS with concerns over AUC Program mandate

Advocacy Letter

May 18, 2022: MGMA provides recommendations to improve the federal Independent Dispute Resolution (IDR) Portal

Advocacy Letter

May 11, 2022: MGMA to HHS: Extend COVID-19 Public Health Emergency

Advocacy Letter

May 4, 2022: MGMA and coalition organizations urge Congress to repeal Section 510 in the Labor-HHS appropriations bill regarding Patient ID

Advocacy Letter

April 27, 2022: MGMA and other healthcare organizations urge Congress to replenish COVID-19 Uninsured Program

Advocacy Letter

April 21, 2022: MGMA sends letter to OSHA outlining concerns over permanent healthcare mandate

Advocacy Letter

April 15, 2022: MGMA to PTAC: Considerations to support practice participation in value-based care models

Advocacy Letter

April 4, 2022: MGMA to CMS: Standardization and additional guidance necessary under the No Surprises Act

Advocacy Letter

March 31, 2022: MGMA and other leading healthcare organizations urge HRSA to exercise flexibility for Period 1 reporting

Advocacy Letter

March 30, 2022: MGMA to CMS: Improvements in value-based care to support health equity

Advocacy Letter

March 29, 2022: MGMA and leading medical organizations urge CMS to propose an alternative strategy for billing split or shared visits

Advocacy Letter

March 23, 2022: MGMA submits comments to ONC on electronic prior authorization standards, implementation, and certification criteria

Press Statement

March 15, 2022: MGMA Statement on MedPAC's March 2022 Report to Congress

Advocacy Letter

March 10, 2022: MGMA and 110 other national healthcare stakeholders urge Congress to extend the Hospital at Home waiver beyond the pandemic

Advocacy Letter

March 7, 2022: MGMA and coalition partners respond to Medicare Advantage RFI related to prior authorization

Advocacy Letter

March 7, 2022: MGMA submits comments to CMS to improve the uninsured and self-pay GFE requirements

Press Statement

March 3, 2022: MGMA Statement on Latest Prior Authorization Data

Advocacy Letter

February 28, 2022: MGMA and partner organizations urge Congress to extend 2% Medicare sequester until the end of the public health emergency

Advocacy Letter

February 25, 2022: MGMA and leading healthcare organizations urge Congress to collaborate with providers on potential Medicare payment reforms

Advocacy Letter

February 23, 2022: MGMA and partner organizations urge Congress to allow sufficient time to evaluate legislation to change regulations for laboratory developed tests independently

Advocacy Letter

February 14, 2022: MGMA and hundreds of healthcare organizations urge HHS to fix, not end, the Direct Contracting Model

Advocacy Letter

February 11, 2022: MGMA and other health organizations urge Congress to modify radiation oncology policies

Advocacy Letter

February 2, 2022: MGMA and leading healthcare organizations support value-based payment arrangements and APMs as a means to prolong solvency of Medicare trust fund

Press Statement

February 2, 2022: MGMA Statement on the Introduction of the SURS Extension Act

Advocacy Letter

January 31, 2022: MGMA and several hundred other organizations ask Congress to extend telehealth flexibilities

Advocacy Letter

January 28, 2022: MGMA sends Congress priorities for inclusion in funding legislation

Advocacy Letter

January 26, 2022: MGMA and other leading organizations voice concerns over United Healthcare’s Designated Diagnostic Provider program

Advocacy Letter

January 26, 2022: MGMA urges HHS to delay uninsured or self-pay good faith estimate requirements

Advocacy Letter

January 12, 2022: MGMA to HHS: Renew COVID-19 PHE

Advocacy Letter

January 6, 2022: MGMA and other leading organizations urge Administration to reevaluate FHIR API policies

Press Statement

January 6, 2022: MGMA Statement on Health Care Value Week

Press Release

January 6, 2022: MGMA Statement on Health Care Value Week

Advocacy Letter

January 5, 2022: MGMA and other leading organizations urge Administration to reevaluate FHIR API policies

Press Statement

December 9, 2021: MGMA Statement on Passage of Legislation Largely Averting Cuts to Medicare

Advocacy Letter

December 6, 2021: MGMA submits comments on Requirements Related to Surprise Billing; Part II

Advocacy Letter

December 6, 2021: MGMA concerns over Medicare cuts that threaten patient access to care

Press Statement

December 2, 2021: MGMA Statement on Congress's Failure to Avert Medicare Cuts

Advocacy Letter

November 30, 2021: MGMA and other leading health organizations urge Congress to prevent cuts to physician labs in 2022

Advocacy Letter

November 29, 2021: MGMA and other leading organizations urge Congress to prevent cuts to Medicare reimbursement in 2022

Advocacy Letter

November 23, 2021: MGMA and other leading health organizations urge CMS to reinstate step therapy prohibition in MA plans for Part B drugs

Press Statement

November 19, 2021: MGMA statement in support of legislation to avert cuts to Medicare payments in CY 2022

Advocacy Letter

November 19, 2021: MGMA and leading health organizations urge Congress to support radiation oncology by preventing cuts in CY 2022

Advocacy Letter

November 19, 2021: MGMA and other health organizations urge Congress to extend the QPP-SURS program

Advocacy Letter

November 17, 2021: MGMA and leading health organizations urge HHS to revise QPA element of IDR process

Press Statement

November 17, 2021: MGMA Statement on the Introduction of Cures 2.0

Advocacy Letter

November 15, 2021: MGMA urges House Ways and Means Committee to hold hearing on Medicare payment cuts

Press Statement

October 20, 2021: MGMA Statement on Introduction of Prior Auth. Reform Bill in Senate

Advocacy Letter

October 14, 2021: MGMA and leading health organizations urge CMS to allow benchmarking flexibility for MSSP ACOs

Advocacy Letter

October 14, 2021: MGMA and coalition of national health organizations urge CMS to clarify and affirm provider right to EFT payments

Advocacy Letter

October 13, 2021: MGMA and other leading health organizations urge Administration to leverage physician practices in COVID-19 vaccine rollout

Advocacy Letter

September 13, 2021: MGMA shares comprehensive comments on 2022 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 9, 2021: MGMA and other national health organizations urge HHS to advance health equity and value through APMs

Advocacy Letter

September 1, 2021: MGMA and other national healthcare organizations urge Congress to increase Medicare support for GME

Advocacy Letter

September 3, 2021: MGMA submits comments to HHS on requirements related to surprise medical billing

Advocacy Letter

August 2, 2021: MGMA and federation of healthcare organizations urge NCVHS to continue support for CPT

Advocacy Letter

August 24, 2021: MGMA urges HHS to extend PRF reporting deadline

Advocacy Letter

August 24, 2021: MGMA and leading health organizations urge inclusion of Value in Health Care Act in reconciliation package

Advocacy Letter

August 20, 2021: MGMA submits comments to OSHA in response to healthcare ETS

Press Statement

August 13, 2021: MGMA calls for prohibition on insurers charging EFT fees

Advocacy Letter

August 11, 2021: MGMA calls on CMS to use its authority to prohibit EFT fees

Press Statement

August 4, 2021: MGMA statement in support of medical group COVID-19 vaccination policies

Advocacy Letter

July 30, 2021: MGMA submits comments to NCVHS on development, adoption, and implementation of new healthcare standards

Advocacy Letter

July 29, 2021: MGMA and other leading healthcare organizations endorse the Seniors’ Chronic Care Management Improvement Act of 2021

Advocacy Letter

July 26, 2021: MGMA and other leading healthcare organizations outline priorities for Medicare telehealth reform

Advocacy Letter

July 23, 2021: MGMA and other national health organizations call on Congress to maintain the 3.75% increase to Medicare conversion factor

Advocacy Letter

July 20, 2021: MGMA and other national health stakeholder groups urge support for the Value in Health Care Act

Press Statement

July 13, 2021: MGMA statement in response to CMS' proposed 2022 physician fee schedule rule

Advocacy Letter

June 30, 2021: MGMA sends letter requesting DOL rescind, delay OSHA healthcare ETS

Advocacy Letter

June 28, 2021: MGMA and other leading healthcare organizations recommend distribution methodology for new GME slots

Advocacy Letter

June 15, 2021: MGMA and coalition of national healthcare groups express support for the Accountable Care In Rural America Act

Advocacy Letter

May 27, 2021: MGMA welcomes new CMS Administrator Chiquita Brooks-LaSure

Advocacy Letter

May 25, 2021: MGMA and other leading healthcare organizations offer recommendations to new CMMI Director to improve APMs

Press Statement

May 20, 2021: New MGMA Poll Shows Prior Authorization on the Rise Despite COVID-19 Pandemic

Advocacy Letter

May 18, 2021: MGMA and other leading health care organizations urge Congress to support physician workforce in upcoming infrastructure package

Advocacy Letter

May 13, 2021: MGMA urges modifications to the Provider Relief Fund

Press Statement

May 13, 2021: MGMA statement on House of Representatives’ proposal to address Medicare Advantage plan prior authorization abuses

Press Statement

May 5, 2021: MGMA statement and comment letter to HHS/OCR Re: proposed modifications to the HIPAA Privacy Rule

Advocacy Letter

May 4, 2021: MGMA and other leading associations ask HHS to delay mandatory MSSP quality reporting changes

Advocacy Letter

May 4, 2021: MGMA submits comments in response to proposed modifications to HIPAA Privacy Rule

Advocacy Letter

April 27, 2021: MGMA and other leading healthcare organizations urge Congress to address FY 2022 Medicare cuts in infrastructure package

Advocacy Letter

April 27, 2021: MGMA submits comments to Ways & Means Health Subcommittee regarding the future of telehealth

April 22, 2021: MGMA and other health organizations urge CMS to reinstate step therapy prohibition on Part B drugs in MA plans

Advocacy Letter

April 19, 2021: MGMA and coalition of national health organizations support legislation to remove negative tax implications from PRF assistance

Advocacy Letter

April 12, 2021: MGMA and coalition of healthcare organizations urge HHS to extend Next Gen ACOs through 2022

Advocacy Statement

April 13, 2021: MGMA applauds passage of legislation that extends the 2% Medicare sequester moratorium

Advocacy Letter

April 13, 2021: MGMA and coalition of national health leaders urge CMS to release MIPS cost measure benchmark data

Advocacy Letter

April 1, 2021: MGMA and other leading health organizations advocate for appropriate patient ID solution

Advocacy Letter

March 24, 2021: MGMA and other health leaders express support for legislation to increase number of Medicare-supported GME positions

Advocacy Statement

March 16, 2021: MGMA statement on Medicare sequester cuts

Advocacy Statement

March 15, 2021: MGMA statement on MedPAC’s Medicare payment policy recommendations

Advocacy Letter

March 12, 2021: MGMA and leading health care advocacy groups urge Congress to prevent Medicare cuts

Advocacy Letter

March 5, 2021: MGMA and other leading health advocacy groups urge CMS to improve MIPS MVPs

Advocacy Letter

March 1, 2021: MGMA submits testimony on "The Future of Telehealth: How COVID-19 is Changing the Delivery of Virtual Care

Advocacy Statement

March 2, 2021: MGMA statement on the Subcommittee on Health of the Committee on Energy and Commerce’s hearing on the future of telehealth

Advocacy Letter

March 1, 2021: MGMA joins coalition urging refinements to Radiation Oncology APM before 2022 start date

Advocacy Letter

Feb. 12, 2021: MGMA joins coalition urging Congress to extend Medicare sequester

Advocacy Letter

Jan. 29, 2021: MGMA letter to House E&C Subcommittee on Oversight & Investigations regarding COVID-19 vaccine hearing

Jan. 27, 2021: MGMA thanks Congress for investing in physician training in Consolidated Appropriations Act, 2021

Advocacy Letter

Jan. 26, 2021: MGMA letter to Biden Administration on inclusion of medical group practices in COVID-19 vaccine distribution strategies

Advocacy Statement

Jan. 15, 2021: MGMA statement on CMS Interoperability and Prior Authorization final rule

Advocacy Letter

Jan. 4, 2021: MGMA comment letter on CMS proposed rule on prior authorization and provider burden

Jan. 4, 2021: MGMA statement on CMS proposed rule on prior authorization

Advocacy Statement

Jan. 4, 2021: MGMA statement on COVID-19 vaccine rollout status

Advocacy Letter

Jan. 4, 2021: MGMA calls on ONC to tie information blocking start date to PHE

Advocacy Statement

December 22, 2020: MGMA statement on Congress’ COVID-19 Stimulus Package

Advocacy Statement

December 18, 2020: MGMA statement on Senate Proposal to Address Prior Authorization

Advocacy Letter

December 14, 2020: MGMA supports congressional effort to mitigate HIPAA fines for practices

December 10, 2020: MGMA statement on the CMS Proposed Rule on Reducing Provider Burden

December 10, 2020: MGMA statement on the Office for Civil Rights HIPAA Proposed Rule

Advocacy Letter

December 3, 2020: MGMA supports Medicare Sequester COVID Moratorium Act

Advocacy Statement

December 1, 2020: MGMA statement on the 2021 Physician Fee Schedule Final Rule

Advocacy Letter

November 27, 2020: MGMA joins effort calling for reevaluation of the CMS Appropriate Use Criteria program

Advocacy Statement

November 23, 2020: MGMA statement on ‘Most Favored Nation’ Interim Final Rule

November 23, 2020: MGMA statement on the Physician Self-referral (Stark) Law and Anti-kickback Statute

Advocacy Letter

November 19, 2020: MGMA and other leading health groups urge Congress to maintain value-based care incentives beyond COVID-19

Advocacy Statement

November 19, 2020: Leading Health Groups Urge Congress to Maintain Value-based Care Incentives Beyond COVID-19

Advocacy Letter

November 7, 2020: MGMA and coalition urge Congress to delay AUC program

Advocacy Statement

November 13, 2020: MGMA asks Congress to extend the moratorium on Medicare sequestration cuts

Advocacy Letter

November 12, 2020: MGMA urges Congress to extend moratorium on Medicare sequestration cuts

Advocacy Letter

November 11, 2020: MGMA joins coalition in support of legislation to prevent Medicare payment cuts in 2021 (HR 8702)

Advocacy Letter

November 10, 2020: MGMA and coalition urge commercial payers to cover supplies necessary to provide safe patient care during COVID-19

Advocacy Letter

November 10, 2020: MGMA and coalition urge CMS to cover supplies necessary to provide safe patient care during COVID-19

Advocacy Statement

November 10, 2020: MGMA statement on the ONC Task Force Report on Prior Authorization

Advocacy Letter

November 5, 2020: MGMA urges CMS to remove deadline to claim missing 2018 APM payments

Advocacy Letter

October 29, 2020: MGMA submits comments to ONC on prior authorization

Advocacy Statement

October 29, 2020: MGMA statement on the ONC interim final rule delaying information blocking requirements until April 5, 2021

Advocacy Statement

October 22, 2020: MGMA poll shows strong opposition to government mandated APMs

Advocacy Letter

October 9, 2020: MGMA joins coalition encouraging legislation to prevent Medicare payment cuts in 2021

Advocacy Letter

October 7, 2020: MGMA joins coalition letter calling for Operating Rules to improve prior authorization

Advocacy Letter

October 2, 2020: MGMA joins coalition urging changes to the final Radiation Oncology Alternative Payment Model

Advocacy Statement

October 1, 2020: MGMA Comments to CMS on Proposed 2021 Physician Fee Schedule

Advocacy Letter

October 1, 2020: MGMA shares comprehensive comments on 2021 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 29, 2020: MGMA calls on ONC to delay enforcement of Information Blocking

Advocacy Letter

September 23, 2020: MGMA urges Senate leaders to support CR and APP modifications

Advocacy Letter

September 23, 2020: MGMA joins coalition to provide comments on proposed 2021 ACO quality changes

Advocacy Letter

August 10, 2020: MGMA submits comments on EHR Reporting Program survey

Advocacy Letter

August 6, 2020: MGMA urges Congress to waive budget neutrality requirements for CY 2021

Advocacy Letter

August 3, 2020: MGMA urges delayed and improved Advance Payment Program repayment conditions

Advocacy Letter

August 3, 2020: MGMA joins coalition to support the Protecting Access to Post-COVID-19 Telehealth Act of 2020

Advocacy Letter

July 30, 2020: MGMA joins coalition urging Congress to lift prohibition on unique patient identifier

Advocacy Letter

July 29, 2020: MGMA joins coalition advocating on surprise billing legislation

Advocacy Statement

July 24, 2020: Press statement on MGMA and coalition supporting the Value in Health Care Act

Advocacy Letter

July 24, 2020: MGMA joins coalition supporting the Value in Health Care Act

Advocacy Letter

July 24, 2020: MGMA Submits Testimony to NCVHS Supporting New Operating Rules to Improve Prior Authorization

Advocacy Letter

July 22, 2020: MGMA urges Senate to include additional assistance for medical groups in next COVID-19 legislation

Advocacy Letter

July 13, 2020: MGMA urges Congress to clarify that PRF payments are nontaxable

Advocacy Letter

July 9, 2020: MGMA joins coalition urging Congress to support the Resident Physician Shortage Reduction Act

Advocacy Letter

July 1, 2020: MGMA joins coalition urging HHS to implement office visit increases and waive budget neutrality

Advocacy Letter

June 30, 2020: MGMA urges HHS to extend public health emergency declaration

Advocacy Letter

June 29, 2020: MGMA joins 340 organizations to ask Congress to extend telehealth flexibilities

Advocacy Letter

June 23, 2020: MGMA joins coalition to ask HHS to continue telehealth waivers

Advocacy Letter

June 17, 2020: MGMA joins coalition urging Congress to extend PPP eligibility to nonprofit organizations in final version of next COVID-19 aid package

Advocacy Letter

June 9, 2020: MGMA joins coalition calling on Congress to include liability protections for physicians in the next COVID-19 relief package

Advocacy Letter

June 3, 2020: MGMA urges Congress to lift prohibition on unique patient identifier

Advocacy Letter

June 2, 2020: MGMA urges HHS to expeditiously disburse unallocated stimulus relief funds to group practices fighting the COVID-19 pandemic

Advocacy Letter

May 22, 2020: MGMA sends letter of support for Senate version of PPP Flexibility Act

Advocacy Letter

May 20, 2020: MGMA sends letter of support for the Paycheck Protection Program Flexibility Act

Advocacy Letter

May 14, 2020: MGMA comments on several provisions of the HEROES Act

Advocacy Letter

May 14, 2020: MGMA joins coalition asking CMS provide additional relief for ACOs

Advocacy Letter

May 6, 2020: MGMA urges SBA to release additional PPP loan forgiveness guidance

Advocacy Letter

April 21, 2020: MGMA asks HHS for clarity on terms and conditions associated with CARES Act Provider Relief funds

Advocacy Letter

April 16, 2020: MGMA asks HHS/CMS to account for providers with low Medicare volumes in next round of CARES Act relief funds

Advocacy Letter

April 15, 2020: MGMA urges Congress to protect the financial viability of group practices

Advocacy Letter

April 10, 2020: MGMA recommends improvements for Medicare's MIPS Value Pathways Program

Advocacy Letter

April 10, 2020: MGMA asks CMS to encourage MA and Part D plans to relax PA and step therapy requirements during COVID

Advocacy Statement

April 14, 2020: MGMA survey sheds light on dire financial impact of COVID-19 on physician practices

Advocacy Statement

April 10, 2020: MGMA statement in response to HHS's initial distribution of $30 billion in grant funds for providers under the CARES Act

Advocacy Letter

April 8, 2020: MGMA joins coalition calling on CMS for E/M payment parity changes and additional telephone E/M guidance for MACs

Advocacy Letter

April 7, 2020: MGMA joins coalition requesting emergency funding for physicians from HHS

Advocacy Letter

April 3, 2020: MGMA submits comments on the 2020-2025 Federal Health IT Strategic Plan

Advocacy Letter

March 27, 2020: MGMA urges HHS to further waive telehealth restrictions following CARES Act

Advocacy Letter

March 27, 2020: MGMA calls on HHS to immediately begin financial support of medical groups

Advocacy Statement

March 27, 2020: MGMA statement on emergency funding for medical practices

Advocacy Letter

March 25, 2020: MGMA joins broad coalition calling on Congress to ensure sustainability of physician practices during COVID-19 emergency

Advocacy Letter

March 20, 2020: MGMA joins coalition calling on Congress to suspend AUC implementation

Advocacy Letter

March 23, 2020: MGMA joins coalition urging Congress to leverage health IT during COVID-19 emergency

Advocacy Letter

March 20, 2020: MGMA joins coalition calling on Congress to ensure sustainability of physician practices during COVID-19 emergency

Advocacy Letter

March 18, 2020: MGMA joins coalition calling on House to ensure access to Medicare value based care during COVID-19 pandemic

Advocacy Letter

March 18, 2020: MGMA joins coalition calling on CMS to allow flexibilities for QPP-participating clinicians

Advocacy Letter

March 18, 2020: MGMA joins coalition calling on Senate to ensure access to Medicare value based care during COVID-19 pandemic

Advocacy Letter

March 18, 2020: MGMA urges Congress to provide direct financial assistance to group practices and take further action on COVID-19

Advocacy Letter

March 11, 2020: MGMA urges HHS to exercise telehealth waiver authority

Advocacy Statement

March 9, 2020: MGMA statement on ONC and CMS interoperability rules

Advocacy Letter

March 2, 2020: MGMA submits comments to CMS on Medicare Advantage Star Rating Program

Advocacy Letter

Feb. 13, 2020: MGMA letter of support for the Consumer Protections Against Surprise Medical Bills Act of 2020

Advocacy Letter

Jan. 31, 2019: MGMA and others urge gradual timeline for removal of MIPS measures

Advocacy Statement

January 21, 2020: MGMA alarmed by new evidence of increasing prior authorization costs for physician practices

Advocacy Letter

Jan. 6, 2020: MGMA joins others to urge passage of Social Determinants Accelerator Act

Advocacy Letter

Dec. 30, 2019: MGMA urges OIG to modernize and clarify the Anti-kickback Statute

Advocacy Letter

Dec. 19, 2019: MGMA urges CMS to modernize and clarify the Stark Law

Advocacy Letter

Dec. 16, 2019: MGMA submits letter to Representatives DeGette and Upton on CURES 2.0

Advocacy Letter

Dec. 9, 2019: MGMA signs on to letter to CMS urging improved patient matching

Advocacy Letter

Dec. 9, 2019: MGMA opposes 45 day billing provision in healthcare legislation

Advocacy Letter

Dec. 4, 2019: MGMA joins coalition supporting Opioid Workforce Act

Advocacy Letter

November 20, 2019: MGMA submits comments to CMS on prior authorization

Advocacy Letter

October 30, 2019: MGMA commends Congress for introduction of bicameral, bipartisan legislation to expand telehealth services to Medicare beneficiaries

Advocacy Letter

October 25, 2019: MGMA submits comments to SAMHSA on substance abuse records proposed rule

Advocacy Letter

October 22, 2019: MGMA joins coalition supporting Rural ACO Improvement Act

Advocacy Letter

October 16, 2019: MGMA and others share concerns with Congress about current surprise billing proposals

Advocacy Statement

October 14, 2019: MGMA survey finds significant increase in regulatory burden on medical practices

Advocacy Statement

October 9, 2019: MGMA statement on CMS' proposed Physician Self-Referral (Stark) rule

Advocacy Statement

September 25, 2019: MGMA statement on CMS proposed physician fee schedule & QPP

Advocacy Statement

September 23, 2019: MGMA Statement on Concerns Regarding ONC's Implementation of 21st Century Cures Act

Advocacy Letter

September 20, 2019: MGMA shares comprehensive comments on 2020 Medicare Physician Fee Schedule proposals

Advocacy Letter

September 23, 2019: MGMA calls on Congress to continue oversight of ONC Cures Act implementation

Advocacy Letter

September 19, 2019: MGMA and 100+ organizations urge comprehensive prior authorization reform

Advocacy Letter

September 16, 2019: MGMA urges CMS to release advanced APM funds

Advocacy Letter

September 9, 2019: MGMA joins 370 stakeholders calling for prior authorization reform

Advocacy Letter

August 27, 2019: MGMA advocates for appropriate patient identification solutions

Advocacy Letter

August 15, 2019: MGMA Responds to Proposed Electronic Prior Authorization Standard

Advocacy Statement

August 12, 2019: MGMA Statement on Patients over Paperwork RFI

Advocacy Letter

August 13, 2019: MGMA Responds to Proposed Section 1557 Revisions

Advocacy Letter

August 12, 2019: MGMA's Response to Patients Over Paperwork RFI

Advocacy Letter

July 16, 2019: MGMA sign-on letter to the Energy and Commerce Committee regarding the No Surprises Act

Advocacy Letter

July 10, 2019: MGMA sends letter to Energy and Commerce Committee in response to No Surprises Act

Advocacy Letter

June 26, 2019: MGMA signs on to letter supporting Opioid Workforce Act

Advocacy Letter

June 25, 2019: MGMA letter supporting legislation removing CCM cost-sharing

Advocacy Letter

June 25, 2019: MGMA response to Senate HELP plan to lower health care costs

Advocacy Letter

June 11, 2019: MGMA letter urging support of the Foster-Kelly amendment to HR 2740

Advocacy Letter

June 5, 2019: MGMA response to Senate HELP Committee's Lower Health Care Costs Act discussion draft

Advocacy Letter

June 5, 2019: MGMA supports prior authorization legislation for MA plans

Advocacy Statement

June 5, 2019: MGMA applauds new prior authorization bill

Advocacy Letter

June 3, 2019: MGMA urges Congress to improve MACRA

Advocacy Letter

June 3, 2019: MGMA and coalition send Patient Matching letter to Congressional leadership

Advocacy Letter

June 3, 2019: MGMA and coalition send letter on 21st Century Cures Act

Advocacy Letter

May 30, 2019: MGMA sends letter to HHS on Next Gen ACOs

Advocacy Statement

May 30, 2019: MGMA supports Administration’s interoperability goals, cautions against added cost, complexity, security risks

Advocacy Letter

May 30, 2019: MGMA provides feedback to CMS regarding the Direct Contracting Geographic Population-based Payment model

Advocacy Letter

May 30, 2019: MGMA submits comments on CMS proposed rule on interoperability

Advocacy Letter

May 30, 2019: MGMA submits comments on ONC proposed rule on interoperability, information blocking, and health IT certification program

Advocacy Statement

MGMA 2019 Advocacy Agenda

Advocacy Letter

5/20/2019: MGMA letter on unexpected medical bills

Advocacy Statement

May 8, 2019: MGMA statement before the U.S. Senate Committee on Finance

Advocacy Letter

May 7, 2019: MGMA sends letter in support of the Safe Step Act of 2019 (H.R. 2279)

Advocacy Letter

April 23, 2019: MGMA joins in opposing H.R. 2143, the "Promoting Integrity in Medicare Act"

Advocacy Letter

April 10, 2019: MGMA and other leading healthcare organizations convey support to the House for the Medicare Care Coordination Act of 2019

Advocacy Letter

April 10, 2019: MGMA and GME coalition send letter in support of the Resident Physician Shortage Reduction Act

Advocacy Letter

April 2, 2019: MGMA and leading healthcare organizations convey support to the Senate for the Medicare Care Coordination Improvement Act of 2019

Advocacy Letter

April 1, 2019: MGMA outlines surprise billing policy framework to Congressional leadership

Advocacy Letter

April 1, 2019: MGMA responds to the Congressional Telehealth Caucus's Request for Information on expanding access to telehealth services

Advocacy Letter

March 26, 2019: MGMA joins coalition calling for Improving Transparency for Innovation Center Models

Advocacy Letter

February 28, 2019: MGMA calls on CMS to address prior authorization use by MA plans

February 7, 2019: MGMA joins stakeholder group sharing concerns on surprise billing

Advocacy Letter

February 12, 2019: MGMA responds to OCR RFI on modifying HIPAA rules

Advocacy Letter

January 28, 2019: MGMA comments in response to ONC publication of "Strategy on Reducing Regulatory and Administrative Burden Relating to the Use of Health IT and EHRs"

Advocacy Letter

January 18, 2019: MGMA and healthcare coalition call on CMS to delay MSSP ACO application deadline

Advocacy Letter

December 6, 2018: MGMA comments on the National Committee on Vital and Health Statistics "Draft Recommendations for the Predictability Roadmap"

Advocacy Letter

Dec. 3, 2018: MGMA and other physician organizations provide feedback to CMS on Open Payments Program educational materials

Advocacy Statement

November 1, 2018: MGMA statement on 2019 Medicare Physician Fee Schedule Final Rule

Advocacy Letter

October 26, 2018: MGMA responds to OIG request for information on the Anti-Kickback Statute

Advocacy Letter

October 17, 2018: MGMA comments on ONC RFI on the CURES Act

Advocacy Letter

October 16, 2018: MGMA submits comments on MSSP proposed rule

Advocacy Letter

September 20, 2018: MGMA and Stakeholder Group Send CMS Letter of Support for ACOs and MSSP

Advocacy Statement

September 20, 2018: MGMA and stakeholder group urge CMS to ensure continued success of ACO program

Advocacy Statement

September 11, 2018: 28 Physician Groups Ask Congress for AUC Program Relief

Advocacy Letter

September 7, 2018: MGMA joins physician organizations opposing step therapy in Medicare Advantage

Advocacy Letter

September 7, 2018: MGMA shares comprehensive comments on Medicare Physician Fee Schedule proposals

Advocacy Letter

September 7, 2018: Physician Groups Ask Congress for AUC Program Relief

Advocacy Letter

September 6, 2018: MGMA commends Congressional efforts to advance regulatory relief initiative

Advocacy Letter

August 27th, 2018: MGMA and coalition of healthcare organizations send CMS a letter on proposed E/M changes

Advocacy Letter

August 24, 2018: MGMA responds to CMS Physician Self-Referral Law Request for Information

Advocacy Letter

August 1, 2018: MGMA joins coalition of healthcare organizations urging Congress to remove barriers to value-based care

Advocacy Letter

July 16, 2018: MGMA comments in response to HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

Advocacy Statement

July 12, 2018: MGMA statement on Release of Physician Fee Schedule Proposed Rule

Advocacy Letter

June 21, 2018: MGMA comments on 2019 IPPS proposed rule

Advocacy Letter

June 25, 2018: Medical Association Coalition response to 2019 IPPS proposed final rule

Advocacy Letter

June 1, 2018: MGMA and a coalition of other leading healthcare organizations send letter to the head of CMMI on APM participation criteria

Advocacy Statement

May 24, 2018: MGMA outlines physician group practice priorities in CMS’ proposed direct contracting model

Advocacy Letter

May 24, 2018: MGMA comments in response to the Center for Medicare and Medicaid Innovation Request for Information on Direct Provider Contracting Models

Advocacy Letter

May 23rd, 2018: MGMA calls on CMS to enforce health plan HIPAA compliance

Advocacy Statement

May 23, 2018: MGMA statement on passage of the VA Maintaining Internal Systems and Strengthening Integrated Outside Networks (VA MISSION) Act of 2018

Advocacy Letter

May 9, 2018: MGMA and other leading healthcare organizations urge Congress to end patient safety issues related to patient matching

Advocacy Letter

April 16, 2018: An urge for CMS to reduce 2018 MIPS reporting period

Advocacy Letter

April 2, 2018: Urging an end electronic payments abuses

Advocacy Statement

March 22, 2018: MGMA statement for Ways and Means MACRA implementation hearing

Advocacy Letter

March 15, 2018: MGMA Responds to Ways and Means RFI on opioid epidemic

Advocacy Statement

March 15, 2018: MGMA statement on Ways and Means Medicare Red Tape Relief Initiative

Advocacy Statement

March 15, 2018: MGMA comment on the MedPAC March 2018 report to Congress

Advocacy Statement

March 1, 2018: MGMA Poll: Medical group practices oppose mandatory Medicare alternative payment models

Advocacy Letter

February 13, 2018: CMS responds to MGMA concerns of MIPS vital information missing

Advocacy Letter

February 22, 2018: MGMA to CMS: Allow ACOs three more years in Track 1

Advocacy Letter

February 2, 2018: MGMA comments on ONC draft Trusted Exchange Framework

Advocacy Letter

February 7, 2018: MGMA administrative burdens letter

Advocacy Letter

January 1, 2018: Consensus Statement on Improving the Prior Authorization Process

Advocacy Letter

January 1, 2018: MGMA comments on proposed 2019 Medicare Advantage, Part D plan changes

Advocacy Letter

January 1, 2018: MGMA to CMS: Immediately release 2018 MIPS eligibility notices

Advocacy Letter

December 13, 2017: MGMA sends letter to Congressional leadership to oppose sequestration cuts to Medicare

Advocacy Letter

November 20, 2017: MGMA response to episode-based cost measures

Advocacy Letter

November 20, 2017: MGMA comments in response to RFI on CMMI's new direction

Advocacy Letter

November 1, 2017: MGMA supports Medicare Care Coordination Improvement Act

Advocacy Letter

November 1, 2017: MGMA supports Medicare Care Coordination Improvement Act

Advocacy Letter

October 23, 2017: MGMA letter to CMS expressing concern about the Clinical Laboratory Fee Schedule (CLFS)

Advocacy Letter

October 16, 2017: MGMA letter to Congressional leadership on CSR payments and marketplace stabilization

Advocacy Letter

October 2, 2017: MACRA letter on CMS flexibility with QPP

Advocacy Letter

September 22, 2017: MGMA letter on Graham-Cassidy Amendment

Advocacy Letter

September 11, 2017: MGMA 2018 CMS Physician Fee Schedule Comment Letter

Advocacy Letter

September 8, 2017: MGMA to CMS: New laboratory payment initiatives could sideline POLs

Advocacy Letter

August 25, 2017: MGMA sends Appendix I Committee Letter

Advocacy Letter

August 21, 2017: MGMA submits comments in response to proposed 2018 Quality Payment Program rule

Advocacy Letter

July 26, 2017: Coalition calls for electronic attachment standards

Advocacy Letter

June 27, 2017: MGMA comments on Better Care Reconciliation Act

Advocacy Letter

June 21, 2017: Track 1+ repayment mechanism letter

Advocacy Letter

June 13, 2017: MGMA IPPS Proposed Rule comment letter

Advocacy Letter

May 31, 2017: MGMA MACRA Medicare Advantage sign-on letter

Advocacy Letter

May 11, 2017: MGMA SSNRI letter to CMS

Advocacy Letter

May 10, 2017: CONNECT for Health Act letter

Advocacy Letter

April 24, 2017: MGMA QPP cost measures comment letter

Advocacy Letter

April 5, 2017: MGMA Labor-H patient matching support letter

Advocacy Letter

March 30, 2017: PAMA sign-on letter

Advocacy Letter

March 22, 2017: MGMA letter commenting on the American Health Care Act of 2017

Advocacy Letter

March 31, 2017: MGMA signs on to letter to CMS regarding Medicare value-based purchasing program penalties

Advocacy Letter

March 15, 2017: MGMA letter to CMS Administrator Verma

Advocacy Letter

March 7, 2017: MGMA comments to FCC on practice use of patient-supplied telephone numbers

Advocacy Letter

February 27, 2017: MGMA signs on to letter to CMS and ONC regarding 2015 CEHRT

Advocacy Letter

February 27, 2017: Letter to CMS and ONC regarding 2015 CEHRT

Advocacy Letter

February 10, 2017: MGMA letter to HHS Secretary Price

Advocacy Statement

January 17, 2018: MGMA statement following the bipartisan Senate Finance committee vote to advance the nomination of Alex Azar for HHS Secretary

Advocacy Letter

December 15, 2016: MGMA comments on the development of a new Medicare ACO model, Track 1 Plus (1+)

Advocacy Letter

August 20, 2016: Joint letter to CMS on removing social security numbers from Medicare ID cards

Advocacy Letter

April 25, 2016: Letter to CMS on provider enrollment process

Advocacy Letter

November 17, 2015: MGMA comments on MACRA RFI

X

Shopping Cart

Your cart is empty

Subtotal:
Click here if your organization is tax exempt
X

A State Sales tax exempt certificate must be on file and taxable items cannot be ordered online. For immediate assistance during normal business hours of 7:00am to 5:00pm MT M-Th and 7:00 am to Noon MT on Friday, please call toll-free: 877-275-6462, ext. 1888

X

Checkout

Use two letter code for US states
Use three letter code for country
Use two letter code for US states
Use three letter code for country
Use two letter code for US states
Use three letter code for country

Grand Total:
Saved credit card is required for opt-in to autorenew.

Questions? Contact the MGMA Service Center for assistance during checkout or review our return policy for more information.
X

Confirmation

,
,

Total:
Payment:
Balance:
 

Thank you for your purchase! If you purchased an event, you will be receiving a follow-up email from our Learning Management System regarding the product/event purchased and no further action is required.


Loading...